# Cetuximab in Treating Patients With Advanced Solid Tumors

> **NCT00376727** · PHASE1 · COMPLETED · sponsor: **University of California, Davis** · enrollment: 27 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** cetuximab
- **GENETIC:** molecular diagnostic method
- **OTHER:** immunologic technique
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00376727
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2007-11
- **Final completion:** 2007-12
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2010-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00376727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00376727, "Cetuximab in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00376727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*